The Mechanisms of the VHL/TPP1/TERT Axis in Reversing HIF2α Inhibitor Resistance in VHL Syndrome-Associated Renal Cell Carcinoma via Telomere Regulation and Its Potential for Combined Targeted Therapy-中华医学会-中华医学会

您目前所在的位置：首页>讲者视频>The Mechanisms of the VHL/TPP1/TERT Axis in Reversing HIF2α Inhibitor Resistance in VHL Syndrome-Associated Renal Cell Carcinoma via Telomere Regulation and Its Potential for Combined Targeted Therapy